Literature DB >> 4747021

Changes of some serum fatty acids and lipids in relation to the clinical course of multiple sclerosis.

J Tichý, J Vymazal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4747021     DOI： 10.1111/j.1600-0404.1973.tb01308.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN： 0001-6314            Impact factor:   3.209


× No keyword cloud information.
  4 in total

1.  Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis.

Authors:  R T Holman; S B Johnson; E Kokmen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.

Authors:  D Bates; N E Cartlidge; J M French; M J Jackson; S Nightingale; D A Shaw; S Smith; E Woo; S A Hawkins; J H Millar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  'Who Am I?': An Exploratory Study of the Relationships Between Identity, Acculturation and Mental Health in Autistic Adolescents.

Authors:  Lily Cresswell; Eilidh Cage
Journal:  J Autism Dev Disord       Date:  2019-07

Review 4.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.